Developed through a public-private partnership, RTS,S malaria vaccine has been recommended by a scientific panel appointed by the WHO to gauge its efficacy. She said the UN Health agency has mobilized funds to support implementation of the initial phase of the malaria vaccine pilot program that covers 2017-2020. Kenya's cabinet secretary for health, Cleopa Mailu, hailed the launch of a malaria vaccine, saying it will accelerate progress toward elimination of the disease. He said the initial pilot program of the RTS,S malaria vaccine will target 700,000 African children. (Xinhua/Daniel Edyegu)NAIROBI, April 25 (Xinhua) -- The World Health Organization (WHO) has unveiled a new malaria vaccine called RTS,S that will be piloted in Kenya, Ghana and Malawi next year to gauge its efficacy and safety.
3 African countries chosen to test 1st malaria vaccine
Three African countries have been chosen to test the world's first malaria vaccine, the World Health Organization announced Monday. Southeast Asia, Latin America and the Middle East also have malaria cases. The malaria vaccine has been developed by pharmaceutical company GlaxoSmithKline, and the $49 million for the first phase of the pilot is being funded by the global vaccine alliance GAVI, UNITAID and Global Fund to Fight AIDS, Tuberculosis and Malaria. Kenya, Ghana and Malawi were chosen for the vaccine pilot because all have strong prevention and vaccination programs but continue to have high numbers of malaria cases, WHO said. Sub-Saharan Africa is hardest hit by the disease, with about 90 percent of the world's cases in 2015.collected by :Lucy William
No comments:
Post a Comment